SCHEMBL24003991

SCHEMBL24003991

Cc1cc(Nc2ccnc(NC(=O)c3ccc(Nc4ccnc(C)c4Cl)cn3)c2)ccn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 1/20 0.43
▸ MAPK10 P53779 1/20 0.43
▸ SMARCA2 P51531 1/20 0.42
▸ SMARCA4 P51532 1/20 0.42
▸ HDAC3 O15379 1/20 0.41
▸ HDAC1 Q13547 1/20 0.41
▸ HDAC2 Q92769 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ SORT1 Q99523 2/20 0.41
▸ ACVRL1 P37023 1/20 0.39
▸ TYK2 P29597 5/20 0.38
▸ JAK2 O60674 4/20 0.38
▸ JAK1 P23458 3/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ AURKA O14965 1/20 0.36
▸ AURKB Q96GD4 1/20 0.36
▸ GRM5 P41594 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24003985 0.88 JAK2 (0.44) SMARCA2SMARCA4HDAC3HDAC1HDAC2
SCHEMBL24003988 0.86 MAPK8 (0.46) MAPK8MAPK10SMARCA2SMARCA4HDAC3
SCHEMBL26322770 0.78 MAPK8 (0.48) MAPK8MAPK10SMARCA2SMARCA4HDAC3
SCHEMBL24003891 0.78 DNMT1 (0.51) MAPK8MAPK10SMARCA2SMARCA4SORT1
SCHEMBL24006278 0.78 DNMT1 (0.56) MAPK8MAPK10SMARCA2SMARCA4SORT1
SCHEMBL24003987 0.75 JAK2 (0.47) MAPK8MAPK10SMARCA2SMARCA4HDAC3
SCHEMBL24003986 0.75 MEN1 (0.46) MAPK8MAPK10HDAC3HDAC1HDAC2
SCHEMBL23999774 0.73 GRM4 (0.44) HDAC3HDAC1HDAC2HDAC6SORT1
SCHEMBL23999808 0.71 MAPT (0.45) KMT2AALDH1A1GAA
SCHEMBL30180568 0.71 MAPT (0.45) KMT2AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 — — US disclosed
WO-2023081854-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2023-05-11 — — WO disclosed
WO-2021226517-A1 AKT3 MODULATORS GEORGIAMUNE LLC (US) 2021-11-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295114-A1 AKT3 MODULATORS AKT3, AKT2, MTOR MAPK8 134/4885MAPK10 60/4885SMARCA2 2506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback